Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population Luis Martín-Penagos, Adalberto Benito, María Victoria Oviedo, Covadonga López del Moral Cuesta, Javier Martín López, Javier Gómez Román, Raquel López-Mejías, Gema Fernandez-Fresnedo, Juan Carlos Ruíz San Millán, Emilio Rodrigo Calabia

The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial Ali Ghorbani, Bita Omidvar, Seyed S. Beladi-Mousavi, Seyed Seifollah Beladi Mousavi, Elena Lak, Sima Vaziri

Progress in understanding the pathogenesis of IgA nephropathy: New perspectives for the near future? Segarra